Accra, March 21, GNA – Precision medicine company Revna Biosciences (RevnaBio) has secured triple accreditation from the American Association for Laboratory Accreditation (A2LA) to strengthen its ...

CODX (NASDAQ:CODX) is making a strategic push to scale its global diagnostics platform, announcing a major expansion of ...

Insight Molecular Diagnostics Inc., (Nasdaq: IMDX), (iMDx), today announced that it will report fourth quarter 2025 financial results after the market closes on Thursday, March 26, 2026. iMDx will ...

Co-Diagnostics Inc. CODX on Friday signed an agreement for CoSara Diagnostics Pvt. Ltd, to expand its commercial and ...

Health ministry has adopted technology to help achieve the goal of eliminating tuberculosis as a public health risk in ...

In a study published today in Nature Medicine, researchers from the University of Oxford and the Muhimbili University of ...

In February, the US Food and Drug Administration granted 510(k) clearance to a dozen in vitro diagnostic tests encompassing molecular, immunoassay, clinical chemistry, and ion selective electrode ...

Karan Arora, senior vice president of advanced assays, AI, and pharma services at Leica Biosystems outlines the critical role diagnostics have to play in unlocking the promise of precision medicine.

Oxford Nanopore Technologies, the company delivering a new generation of molecular sensing technology based on nanopores, and ...

Research published in ACS Central Science could help healthcare professionals non-invasively diagnose bacterial infections, using breath-based tests.

Led by YSPH and partners at CIDEIM at Icesi University, the research team conducted the study in Cali, Colombia.

Chronic hepatitis D virus (HDV) coinfection in people with chronic hepatitis B is associated with rapid progression to liver cirrhosis and high mortality. In 2020, the estimated global HDV burden ...